Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading up 48 points (0.3%) at 16,465 as of Friday, Jan. 17, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,451 issues advancing vs. 1,447 declining with 177 unchanged. The Health Care sector currently sits up 0.5% versus the S&P 500, which is down 0.1%. On the negative front, top decliners within the sector include Edwards Life ( EW), down 4.6%, Herbalife ( HLF), down 4.2%, Grifols ( GRFS), down 1.6%, St Jude Medical ( STJ), down 1.0% and Pfizer ( PFE), down 0.6%. Top gainers within the sector include Intercept Pharmaceuticals ( ICPT), up 10.8%, Align Technology ( ALGN), up 3.6%, Intuitive Surgical ( ISRG), up 2.9%, Jazz Pharmaceuticals ( JAZZ), up 2.5% and Shire ( SHPG), up 1.6%. TheStreet would like to highlight 5 stocks pushing the sector lower today: 5. Mindray Medical International Limited ADR r ( MR) is one of the companies pushing the Health Care sector lower today. As of noon trading, Mindray Medical International Limited ADR r is down $1.99 (-5.0%) to $38.21 on heavy volume. Thus far, 971,125 shares of Mindray Medical International Limited ADR r exchanged hands as compared to its average daily volume of 1.1 million shares. The stock has ranged in price between $37.50-$40.00 after having opened the day at $38.95 as compared to the previous trading day's close of $40.20. Mindray Medical International Limited, through its subsidiary, Shenzhen Mindray, develops, manufactures, and markets medical devices worldwide. It operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. Mindray Medical International Limited ADR r has a market cap of $4.7 billion and is part of the health services industry. The company has a P/E ratio of 21.6, above the S&P 500 P/E ratio of 17.7. Shares are up 10.4% year-to-date as of the close of trading on Thursday. Currently there are 5 analysts that rate Mindray Medical International Limited ADR r a buy, 1 analyst rates it a sell, and 2 rate it a hold. TheStreet Ratings rates Mindray Medical International Limited ADR r as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, good cash flow from operations and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Mindray Medical International Limited ADR r Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.